GGCT participates in the malignant process of hepatocellular cancer cells by regulating the PTEN/PI3K/AKT pathway through binding to EZH2 - He, Junbo; Wang, Liangzhi; Lv, Mengjia; Yuan, Yiming (Discover. Oncology, 2025)
Keywords: Antibodies; Apoptosis; Cancer Research; Cancer therapies; Cell growth; Enhancer of zeste homolog 2; Flow cytometry; Glycolysis; Hepatocellular carcinoma; Internal Medicine; Liver cancer; Medical prognosis; Medicine; Medicine & Public Health; Molecular Medicine; Oncology; Proteins; PTEN/PI3K/AKT; Radiotherapy; Surgical Oncology; Tumors; γ-Glutamylcyclotransferase; United States--US; China; Shanghai China; Glycolysis; γ-Glutamylcyclotransferase; Hepatocellular carcinoma; PTEN/PI3K/AKT; Enhancer of zeste homolog 2